VitalStone Financial LLC purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,857 shares of the medical research company’s stock, valued at approximately $439,000. A number of other hedge […]
VitalStone Financial LLC purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 1,857 shares of the medical research company’s stock, valued at approximately $439,000. Other hedge funds have also recently added to or reduced their stakes in the company. VisionPoint […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Thursday. Several other analysts have also recently issued reports on the company. Robert W. Baird dropped their target price on Charles River Laboratories International from $282.00 […]
Bell Asset Management Ltd lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 13.7% during the fourth quarter, Holdings Channel reports. The firm owned 43,439 shares of the medical research company’s stock after selling 6,868 shares during the quarter. Charles River Laboratories International makes up about 1.6% of […]
Nicholas Company Inc. increased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 17.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 70,681 shares of the medical research company’s stock after acquiring an additional 10,695 shares during […]